Stay up to date with news and events
Blue skies for Skyhawk: Positive news from Phase 1 trial for SKY-0515
July 13, 2024
The stormy trial updates that hung over the Huntington’s disease (HD) field in 2021 have certainly parted, making way for the bright and clear forecast…
Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial
July 12, 2024
New data from uniQure, who developed a one-and-done gene therapy for Huntington’s disease (HD) called AMT-130, indicates that the drug is relatively safe and might…
Positive news from Wave Life Sciences SELECT-HD trial
June 27, 2024
On 25th June 2024, Wave Life Sciences shared the results of their SELECT-HD clinical trial. This trial tested a therapy called WVE-003, designed to only…
Wave Life Sciences Announces Positive Results from Phase 1B/2A SELECT-HD Trial
June 26, 2024
Great news on the positive results! Read all the details below. Community Letter Press Release
No pivot needed for PTC-518
June 22, 2024
On June 20, 2024, we received an update from PTC Therapeutics about their ongoing trial, PIVOT-HD. PIVOT is testing PTC-518, a small molecule drug, taken…